Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development—Pediatric Formulations Initiative, Part 1

Author(s):  Giacoia George P, Taylor-Zapata Perdita, Mattison Donald

Issue:  Jan/Feb 2007 - Pediatric Patients
View All Articles in Issue

Abstract:  The development and compounding of pharmacotherapeutic formulations that are suitable for infants and young children can be a challenging problem. This problem results from the lack of knowledge on the acceptability of different dosage forms and formulations in children in relation to age and developmental status, as well as the lack of reliable documentation of formulations used in pediatric clinical trials. As part of its mandate under the Best Pharmaceuticals for Children Act to improve pediatric therapeutics, the National Institute of Child Health and Human Development has sponsored the Pediatric Formulation Initiative. The goal of this ongoing initiative is to address the issues and concerns associated with pediatric therapeutics by convening groups of researchers and experts in pediatric formulations from academia, pharmaceutical companies, the National Institutes of Health, and the U.S. Food and Drug Administration.

Related Keywords: NIH, NICHD, EXTEMPORANEOUS, NATIONAL INSTITUTE FOR CHILD HEALTH AND HUMAN DEVELOPMENT, CHILDREN, INFANTS, USP, UNITED STATES PHARMACOPEIA, OFF-LABEL, FDA, FDAMA, US FOOD AND DRUG ADMINISTRATION, UNITED KINGDOM, NATIONAL HEALTH SERVICE, REGULATORY AGENCY,

Related Categories: EXCIPIENTS, LEGAL, PEDIATRICS, PATIENT COMPLIANCE, DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version




Download in electronic PDF format for $35

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>,<797>, and <825>: Part 1 Allen Loyd V Jr Mar/Apr 2020 92 Buy
PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>, <797>, and <825>: Part 2 Allen Loyd V Jr May/Jun 2020 180 Buy
Safety Standards in Pharmaceutical Compounding, Part 2: A Closer Look at Agency Information, Oversight, and Assistance Greeson Nicole MH, Mixon William, Allan W Chris Sep/Oct 2020 371-379 Buy
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2 Giacoia George P, Taylor-Zapata Perdita, Mattison Donald May/Jun 2007 220-225 Buy
PreScription: Stability Studies and United States Pharmacopeia-National Formulary-Grade Chemicals Allen Loyd V Jr Sep/Oct 2016 356 Buy
Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1 Martin Matt Sep/Oct 2018 401-404 Buy
Healthful Living: Good Practices for Good Health Jackson Kathy May/Jun 2002 164-166 Buy
Oral Rehydration Salts (World Health Organization/United Nations Children's Fund) Allen Loyd V Jr Sep/Oct 2006 390 Buy
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development—Pediatric Formulations Initiative, Part 1 Giacoia George P, Taylor-Zapata Perdita, Mattison Donald Jan/Feb 2007 5-8 Buy
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr Jul/Aug 2016 351 View Sample